shstuebingen Current page: 3

CAM Bioceramics B.V., based in Leiden, the Netherlands, is a leading global manufacturer of innovative calcium phosphate solutions for Medtech and LifeScience applications Together with ING Corporate Investments and several Co-Investors, the German specialist healthcare investor acquires a majority stake in the company, while current owners remain significant shareholders This investment is the third transaction […]

Spiegelberg GmbH & Co. KG is one of the leading suppliers in the field of manufacturing devices and consumables for intracranial pressure measurement and has been able to grow strongly in recent years  Luciole Medical AG, which specialises in cerebral monitoring and measurement of oxygen saturation in the brain, is expanding its product range with […]

SHS partners with the founders of MESI, a fast-growing Slovenia-based diagnostic company growing revenues >50% p.a. in the last 5 years MESI’s cutting-edge technology digitalizes medical assessment, resulting in workflow optimisation, cost saving and improved patient outcomes The investment aims to further accelerate MESI’s growth and global market presence, and help to transform healthcare with […]

Ruth Ch. Gessner has been SHS Senior Advisor since the beginning of 2023. She specializes in the profitable realignment of companies in the medical technology sector. Over the past 20 years, she has successfully led business units as Vice President at Danaher / Dental as well as at other leading listed corporations. She was also […]

Siegfried Schabel has held the dual role of CEO and CFO for Tyromotion since October 2022. In his last role, he was CEO of a global group with business areas in medical devices (in-vitro diagnostics), cutting machines and products for the welding, soldering and thermal coating markets. Mr. Schabel on Tyromotion GmbH: “It is a […]

Develco Pharma AG has elected a new chairman of its board of directors. The previous chairman, Markus Zimmer, has handed over his office to the newly elected chairman, Steffen Wagner. Mr. Wagner has broad general management experience in international life science businesses. He is a medical doctor by training, has previously held senior roles with […]

TRI Dental Implants Int. AG was able to win Patterson Dental as an authorized distribution partner for its TRI® matrix® implant system, which thus becomes the first dental implant without abutment in the United States. Using digital fabrication technologies such as 3D printers and CAD/CAM milling machines, TRI-Matrix implant technology enables a 3-5-fold increase in […]

Our SHS portfolio company Selfapy has closed a 7 million euro funding round. MEDICE Arzneimittel Pütter GmbH & Co KG has come on board as a new investor. In addition, all existing investors have participated in the new financing round. The aim of the investment is to establish further digital health applications for mental illnesses […]

After the Scandinavian start-up Dr.Dropin has already opened 25 clinic locations in Norway, the digital-analogue health provider is now conquering other countries. In Sweden, the company already has two branches. Now Dr.Dropin also wants to open its first clinic in Switzerland. Click here for the full article: LINK

SIS Medical AG (Swiss Interventional Systems), a leading global developer, manufacturer and distributor of high-quality, high-performance interventional cardiology products, announces the US launch of its flagship product, the OPN NC® PTCA Dilatation Catheter with TWIN-Wall Technology. The product expands treatment options with high performance and safety, providing success rates where other balloons fail. The OPN […]

1. You have been part of the SHS team since September 2022. Before that, you were an associate at a renowned investment bank in Frankfurt. What was your field of activity there? I was employed as an analyst for 2.5 years before I was promoted to associate shortly before leaving. I mainly worked on M&A […]

SHS invests €10 million euro from its newly launched sixth fund generation into the Zurich-based growth company Simulands AG develops, produces, and distributes innovative simulation devices and tools for cardiovascular interventions The investment aims to further accelerate the commercialisation of the company and help revolutionise cardiovascular education and training through advanced training solutions for physicians […]